These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 2373671)

  • 1. Anaerobic susceptibility tests: differences between disc diffusion, agar dilution and broth microdilution test results.
    Barry AL
    J Antimicrob Chemother; 1990 May; 25(5):875-7. PubMed ID: 2373671
    [No Abstract]   [Full Text] [Related]  

  • 2. Susceptibility results for the Bacteroides fragilis group: comparison of the broth microdilution and agar dilution methods.
    Hecht DW; Lederer L; Osmolski JR
    Clin Infect Dis; 1995 Jun; 20 Suppl 2():S342-5. PubMed ID: 7548593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The microdilution antibiotic susceptibility test. Bacteroides fragilis.
    Steingrimsson O; Ryan RW; Tilton RC
    Am J Clin Pathol; 1976 Jun; 65(6):1010-5. PubMed ID: 1047602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of EUCAST disk diffusion method for susceptibility testing of the Bacteroides fragilis group isolates.
    Nagy E; Justesen US; Eitel Z; Urbán E;
    Anaerobe; 2015 Feb; 31():65-71. PubMed ID: 25464140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standardization of antimicrobial disc susceptibility test for anaerobic bacteria.
    Ho SW
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1976 Dec; 9(3-4):55-62. PubMed ID: 1037535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of sulfamethoxazole trimethoprim against Bacteroides fragilis.
    Nadaud M
    Zentralbl Bakteriol Orig A; 1978 Nov; 242(1):79-84. PubMed ID: 735555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Media- and method-dependent variation in MIC values of ceftizoxime for clinical isolates of the Bacteroides fragilis group.
    Wexler HM; Finegold SM
    J Chemother; 1991 Feb; 3 Suppl 2():12-9. PubMed ID: 2040893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility testing of anaerobic bacteria.
    Citron D
    Am J Med Technol; 1983 Nov; 49(11):769-72. PubMed ID: 6316785
    [No Abstract]   [Full Text] [Related]  

  • 9. Antimicrobial susceptibility testing of anaerobic bacteria.
    Sutter VL
    Am J Med Technol; 1976 Apr; 42(4):111-4. PubMed ID: 1266883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro activity of the oxa-beta-lactam LY 127935 against Bacteroides fragilis and other anaerobic gram-negative rods (author's transl)].
    Werner H; Krasemann C
    Infection; 1980; 8 Suppl 3():S 342-6. PubMed ID: 6447673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro susceptibility of the Bacteroides fragilis group and the inoculum effect of newer beta-lactam antibiotics on this group of organisms.
    Jacobus NV; Cuchural GJ; Tally FP
    J Antimicrob Chemother; 1989 Nov; 24(5):675-82. PubMed ID: 2599992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Media- and method-dependent variation in MIC values of ceftizoxime for clinical isolates of the Bacteroides fragilis group.
    Wexler HM; Finegold SM
    Clin Ther; 1990; 12 Suppl C():13-24. PubMed ID: 2390771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the disc-plate method in Bacteroides fragilis].
    García Rodríguez JA; García Sánchez JE; Gómez Garciá AC; Prieto Prieto J
    Rev Clin Esp; 1977 Aug 15-31; 146(3-4):161-6. PubMed ID: 918321
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of the E-test for susceptibility testing of the Bacteroides fragilis group. Danish study group.
    Bremmelgaard A; Jansen JE; Justesen T; Gottschau A
    APMIS; 1994 Jun; 102(6):446-50. PubMed ID: 8068304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of Bacteroides fragilis to cefotaxime and piperacillin: tentative interpretative standards for the disc-diffusion test.
    Luzzi I; Pantosti A; Gianfrilli P; Panichi G
    Eur J Clin Microbiol; 1984 Feb; 3(1):37-9. PubMed ID: 6323174
    [No Abstract]   [Full Text] [Related]  

  • 16. Anaerobic susceptibility tests. Evaluation of the stability of antimicrobials in Wilkens-Chalgren broth and the effect of media prereduction.
    Murray PR; Christman JL
    J Antibiot (Tokyo); 1978 Dec; 31(12):1296-8. PubMed ID: 738968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibility testing of Bacteroides fragilis using the MALDI Biotyper antibiotic susceptibility test rapid assay (MBT-ASTRA).
    Justesen US; Acar Z; Sydenham TV; Johansson Å;
    Anaerobe; 2018 Dec; 54():236-239. PubMed ID: 29501419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Susceptibility testing of anaerobes (author's transl)].
    Werner H
    Immun Infekt; 1978 Dec; 6(6):253-9. PubMed ID: 365718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of apparently pure anaerobic cultures: a possible source of error in susceptibility testing.
    Reig M; Baquero F
    Eur J Clin Microbiol; 1984 Aug; 3(4):323-4. PubMed ID: 6386463
    [No Abstract]   [Full Text] [Related]  

  • 20. [Isolation of anaerobic bacteria from clinical specimens and the drug susceptibility of Bacteroides fragilis].
    Ho SW; Hsien WC
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1977 Jun; 10(1-2):8-13. PubMed ID: 578133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.